import React from 'react';
import './Blog.css';

function Blog() {
    return (
        <div className="blog-page">
            <div className="blog-hero">
                <h1 className="blog-title">BioX Blog</h1>
                <p className="blog-subtitle">Insights, Updates, and Stories from the BioX Community</p>
            </div>
            
            <div className="blog-container">
                <div className="blog-content">
                    <article className="blog-article">
                        <h2>The Silent Empire: Inside ABC Pharmaceuticals and the Men Who Redefined Science</h2>
                        
                        <p>There are companies that change medicine, and then there are those that change the rules of nature itself. ABC Pharmaceuticals belongs to the latter. Hidden behind frosted glass walls and guarded NDAs, this mysterious biotech empire has become a quiet legend in the scientific world — a place where boundaries blur, ethics bend, and discovery takes precedence over everything else.</p>
                        
                        <p>At the center of this empire stands Ayush Mohapatra — a man of few appearances and fewer words. He's the sole owner of ABC Pharmaceuticals, yet his public presence is nearly non-existent. His company has no investors, no shareholders, no board. It is, quite literally, an empire of one mind.</p>
                        
                        <p>But those who've met him say Ayush doesn't speak like a businessman; he speaks like someone who's seen too much of what science can do. His vision is both magnetic and unsettling — the kind of brilliance that feels one breakthrough away from either saving or ending the world.</p>
                        
                        <p>And just behind him, always a few paces away, stands Adwai — ABC's chief corporate representative and Ayush's most trusted confidant. Adwai's calm is legendary. Former interns joke that he could negotiate with a storm and convince it to wait until after the press conference. He handles the public face of ABC — or at least, what little of it the public is allowed to see.</p>
                        
                        <p>The two men are rarely photographed together, and yet every whisper about ABC begins and ends with their names.</p>
                        
                        <p>Inside the company, the research divisions are run like small countries. Each team has its own head, its own sealed lab, and even its own coded clearance system. Dr. Shriya, the molecular biologist responsible for ABC's regenerative cell platform, once described the experience as "working inside a brain — every lab a neuron, and Ayush the mind connecting them all."</p>
                        
                        <p>Then there's Husayn, a former biochemist turned security director, who reportedly left the Indian Defense Research wing to join Ayush's vision. His department oversees what employees cryptically call The Lower Floor — a level of the ABC complex that doesn't appear on any architectural plan. Few ever go down there, and those who do are never quite the same after.</p>
                        
                        <p>Rumors suggest that The Lower Floor houses the company's most controversial asset: Ricin.</p>
                        
                        <p>The compound is not for public sale, not even for research partnerships, and certainly not listed in ABC's catalog. Yet multiple sources claim that ABC Pharmaceuticals is the only organization on the planet capable of synthesizing Ricin in its purest, most controlled form. Even more astonishingly, only Ayush has direct access to it.</p>
                        
                        <p>No password, no fingerprint, no clearance overrides his. If Ayush doesn't open that vault, it stays closed. Permanently.</p>
                        
                        <p>When asked about the existence of Ricin, Adwai once smiled faintly in an interview and said, "Some doors are meant to stay closed — until humanity is ready." That was the first and last time anyone at ABC ever acknowledged the topic publicly.</p>
                        
                        <p>But the story of Ayush cannot be told without mentioning Gaurish, the visionary CEO of BioX Pharmaceuticals — his closest friend, and perhaps his greatest philosophical opposite. Gaurish believes in open science, in making every discovery a public triumph.</p>
                        
                        <p>The two men's friendship, born in shared curiosity during their years at college, has survived rivalries, betrayals, and breakthroughs. Late-night calls between them have shaped the course of modern biotech, though no transcript or recording of those conversations has ever surfaced.</p>
                        
                        <p>As one insider put it: "Gaurish wants to heal the world. Ayush wants to make sure the world survives being healed."</p>
                        
                        <p>Between them exists a tension — one driven by faith, and the other by control.</p>
                        
                        <p>Beyond these towering figures, ABC's internal web extends further — Nandini, the neuropharmacologist who vanished midway through a project that supposedly involved "neural Ricin blockers"; Arnab, the data scientist tasked with simulating chemical behavior in living systems; Dr. Kashyapi, a behavioral biochemist whose role remains shrouded in secrecy and Dr. Kaushal the youngest of Ayush's recruits, who once described him in a leaked memo as "a man haunted by the cure he hasn't found yet."</p>
                        
                        <p>No one outside ABC knows what the company's next project is. The last official press release was over three years ago. Since then, it's been silence — except for the faint hum that residents nearby say they hear on quiet nights, like a low electrical pulse deep underground.</p>
                        
                        <p>Some say Ayush is perfecting something greater than medicine — something that could alter human biology itself. Others whisper that he's building an antithesis to VX-1, a compound designed not to heal but to control, to contain, to neutralize whatever humanity isn't meant to wield.</p>
                        
                        <p>Whatever the truth may be, ABC Pharmaceuticals stands as a monument to brilliance wrapped in secrecy. Ayush Mohapatra doesn't attend conferences. He doesn't publish papers. Yet every scientist, every researcher, every rival knows his name.</p>
                        
                        <p>And perhaps that's the way Ayush wants it. Because sometimes, the greatest discoveries aren't meant for the world — they're meant to keep the world safe from what it could become.</p>
                    </article>
                </div>
            </div>
        </div>
    );
}

export default Blog;